Live Breaking News & Updates on Leonard Mazur

Stay updated with breaking news from Leonard mazur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Citius Pharmaceuticals, Inc. Receives a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for LYMPHIR™ (Denileukin Diftitox) for the Treatment of Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma

No clinical efficacy or safety issues raised
Citius committed to working toward approval
CRANFORD, N.J., July 29, 2023 /PRNewswire/ Citius Pharmaceuticals, Inc. today announced that the U.S.. ....

Ilanit Allen , Leonard Mazur , Greg Salsburg , Company Biologics License Application , Securities Exchange , Exchange Commission , Citius Pharmaceuticals Inc , Company Nasdaq , Prnewswire Citius Pharmaceuticals Inc , Drug Administration , Complete Response Letter , Biologics License Application , Citius Pharmaceuticals , Fast Track , Securities Act , Securities Exchange Act , Annual Report ,

Citius Pharmaceuticals to be Added to Russell 3000® and Russell 2000® Indexes

CRANFORD, N.J., June 26, 2023 /PRNewswire/ Citius Pharmaceuticals, Inc. ( ....

Leonard Mazur , Ilanit Allen , Greg Salsburg , Citius Pharmaceuticals Inc , Securities Exchange , Company Nasdaq , Exchange Commission , Citius Pharmaceuticals , Fast Track , Securities Act , Securities Exchange Act , Annual Report ,

Citius Pharmaceuticals (CTXR) Reports Positive Results from the Phase 2b Study of Halo-Lido

Citius Pharmaceuticals (CTXR) Reports Positive Results from the Phase 2b Study of Halo-Lido
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Leonard Mazur , Myron Czuczman , Citius Pharmaceuticals Inc , Company Phase , Drug Administration , Citius Pharmaceuticals , Halo Lido Phase , Century Cures Act , Patient Reported Outcome , Hemorrhoid Quality , Life Index , Trial Results , Meaningful Change Threshold , Chief Medical Officer ,

Citius Pharmaceuticals Announces Positive Results from the Phase 2b Study of Halo-Lido (CITI-002) for the Treatment of Hemorrhoids

CITI-002 provides a meaningful reduction in symptom severity when compared to individual components alone
Dose for Phase 3 trial selected; Citius to schedule end of Phase 2 meeting with the. | June 20, 2023 ....

Ilanit Allen , Leonard Mazur , Myron Czuczman , Greg Salsburg , Citius Pharmaceuticals Inc , Company Phase , Securities Exchange , Exchange Commission , Prnewswire Citius Pharmaceuticals Inc , Drug Administration , Patient Reported Outcome , Halo Lido Phase , Century Cures Act , Hemorrhoid Quality , Life Index , Trial Results , Meaningful Change Threshold , Chief Medical Officer , Citius Pharmaceuticals , Fast Track , Securities Act , Securities Exchange Act , Annual Report ,

Citius Pharmaceuticals to Participate in Maxim Group's Virtual Healthcare Conference on June 21, 2023

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development. ....

Leonard Mazur , Michael Okunewitch , Ilanit Allen , Prnewswire Citius Pharmaceuticals Inc , Maxim Group Virtual Healthcare Conference On , Company Nasdaq , Citius Pharmaceuticals Inc , Senior Biotech Research Analyst , Maxim Group , Virtual Healthcare Conference , Citius Pharmaceuticals , Fast Track , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Trade Show News ,